Filing Details

Accession Number:
0001123292-17-001501
Form Type:
4
Zero Holdings:
No
Publication Time:
2017-10-04 16:42:22
Reporting Period:
2017-10-03
Accepted Time:
2017-10-04 16:42:22
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
881524 Vivus Inc VVUS Pharmaceutical Preparations (2834) 943136179
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
1640688 T Santosh Varghese C/O Vivus, Inc.
900 E. Hamilton Ave., Suite 550
Campbell CA 95008
Chief Medical Officer No Yes No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Disposition 2017-10-03 434 $0.97 72,740 No 4 S Direct
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 S Direct
Footnotes
  1. Sold to pay the tax liability resulting from the vesting of 919 restricted stock units granted on January 23, 2015.